Japan
# |
Name |
Revenue Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 194.47
|
March 31, 2024 | USD 30.78 | 0.24% |
|
Japan |
|
2 |
USD 160.51
|
March 31, 2024 | USD 5.61 | 1.24% |
|
Japan |
|
3 |
USD 153.68
|
May 31, 2024 | USD 14.65 | 0.72% |
|
Japan |
|
4 |
USD 151.21
|
March 31, 2024 | USD 27.25 | 2.68% |
|
Japan |
|
5 |
USD 134.33
|
May 31, 2024 | USD 60.33 | -0.89% |
|
Japan |
|
6 |
USD 123.83
|
June 30, 2024 | USD 13.60 | -1.16% |
|
Japan |
|
7 |
USD 111.02
|
March 31, 2024 | USD 14.52 | -1.32% |
|
Japan |
|
8 |
USD 98.48
|
March 31, 2024 | USD 13.10 | -1.23% |
|
Japan |
|
9 |
USD 84.59
|
March 31, 2024 | USD 17.61 | 0.19% |
|
Japan |
|
10 |
USD 77.40
|
May 31, 2024 | USD 47.15 | -2.11% |
|
Japan |
|
11 |
USD 76.41
|
March 31, 2024 | USD 7.67 | 0.04% |
|
Japan |
|
12 |
USD 75.16
|
March 31, 2024 | USD 9.05 | 0.26% |
|
Japan |
|
13 |
USD 73.39
|
June 30, 2024 | USD 5.93 | 2.56% |
|
Japan |
|
14 |
USD 72.13
|
April 30, 2024 | USD 30.05 | 0.04% |
|
Japan |
|
15 |
USD 70.78
|
Feb. 29, 2024 | USD 14.53 | 1.80% |
|
Japan |
|
16 |
USD 56.29
|
March 31, 2024 | USD 9.69 | -0.16% |
|
Japan |
|
17 |
USD 48.39
|
Feb. 29, 2024 | USD 12.88 | 1.45% |
|
Japan |
|
18 |
USD 48.32
|
Oct. 31, 2024 | USD 70.73 | 0.14% |
|
Japan |
|
19 |
USD 44.19
|
March 31, 2024 | USD 13.53 | -0.08% |
|
Japan |
|
20 |
USD 43.95
|
May 31, 2024 | USD 5.40 | 1.54% |
|
Japan |
|
21 |
USD 42.47
|
March 31, 2024 | USD 26.82 | -0.32% |
|
Japan |
|
22 |
USD 39.22
|
Feb. 29, 2024 | USD 14.18 | -1.56% |
|
Japan |
|
23 |
USD 37.89
|
June 30, 2024 | USD 19.29 | -1.44% |
|
Japan |
|
24 |
USD 32.89
|
May 31, 2024 | USD 3.19 | 0.04% |
|
Japan |
|
25 |
USD 31.96
|
March 31, 2024 | USD 10.06 | -1.25% |
|
Japan |
|
26 |
USD 30.87
|
March 31, 2024 | USD 44.71 | 2.93% |
|
Japan |
|
27 |
USD 30.60
|
March 31, 2024 | USD 19.21 | -0.30% |
|
Japan |
|
28 |
USD 29.05
|
March 31, 2024 | USD 6.14 | 0.04% |
|
Japan |
|
29 |
USD 28.62
|
May 31, 2024 | USD 21.25 | 0.57% |
|
Japan |
|
30 |
USD 27.42
|
Feb. 29, 2024 | USD 17.26 | -1.83% |
|
Japan |
|
31 |
USD 26.68
|
March 31, 2024 | USD 12.53 | -1.57% |
|
Japan |
|
32 |
USD 26.18
|
March 31, 2024 | USD 20.13 | -0.09% |
|
Japan |
|
33 |
USD 25.74
|
March 31, 2024 | USD 15.30 | -0.34% |
|
Japan |
|
34 |
USD 25.35
|
March 31, 2024 | USD 2.65 | 0.55% |
|
Japan |
|
35 |
USD 24.77
|
March 31, 2024 | USD 17.62 | 1.84% |
|
Japan |
|
36 |
USD 23.77
|
March 31, 2024 | USD 8.98 | -3.78% |
|
Japan |
|
37 |
USD 20.41
|
July 31, 2024 | USD 7.15 | -0.42% |
|
Japan |
|
38 |
USD 20.03
|
May 31, 2024 | USD 9.43 | -0.58% |
|
Japan |
|
39 |
USD 19.00
|
May 31, 2024 | USD 13.48 | -0.05% |
|
Japan |
|
40 |
USD 18.95
|
March 31, 2024 | USD 22.12 | 0.19% |
|
Japan |
|
41 |
USD 18.58
|
March 31, 2024 | USD 6.71 | -0.35% |
|
Japan |
|
42 |
USD 18.01
|
March 31, 2024 | USD 27.32 | -0.70% |
|
Japan |
|
43 |
USD 17.86
|
March 31, 2024 | USD 8.80 | -0.26% |
|
Japan |
|
44 |
USD 17.63
|
March 31, 2024 | USD 2.97 | 3.26% |
|
Japan |
|
45 |
USD 17.09
|
March 31, 2024 | USD 29.76 | 0.15% |
|
Japan |
|
46 |
USD 16.58
|
March 31, 2024 | USD 11.63 | 0.67% |
|
Japan |
|
47 |
USD 16.17
|
March 31, 2024 | USD 14.63 | 0.41% |
|
Japan |
|
48 |
USD 15.51
|
March 31, 2024 | USD 3.70 | -7.87% |
|
Japan |
|
49 |
USD 14.89
|
March 31, 2024 | USD 12.66 | 1.47% |
|
Japan |
|
50 |
USD 14.57
|
July 31, 2024 | USD 6.39 | -0.78% |
|
Japan |
The Healthcare company in Japan with the highest Revenue Per Share is Suzuken Co., Ltd. (Tokyo Stock Exchange: 9987.T) at USD 194.47.
The Healthcare company in Japan with the lowest Revenue Per Share is StemRIM (Tokyo Stock Exchange: 4599.T) at USD 0.00.
The top 10 Healthcare companies in Japan by Revenue Per Share are Suzuken Co., Ltd., Ohki Healthcare Holdings Co.,Ltd., Yamashita Health Care Holdings,Inc., Toho Holdings Co., Ltd., Tsuruha Holdings Inc., OLBA HEALTHCARE HOLDINGS, Inc., MediPal Holdings Corporation, Alfresa Holdings Corporation, Cawachi Limited and COSMOS Pharmaceutical Corporation.
The bottom 10 Healthcare companies in Japan by Revenue Per Share are StemRIM, SanBio Company Limited, BrightPath Biotherapeutics Co., Ltd., NanoCarrier Co., Ltd., OncoTherapy Science, Inc., MEDINET Co., Ltd., Oncolys BioPharma Inc., Solasia Pharma K.K., ReproCELL Incorporated and Japan Tissue Engineering Co., Ltd..